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ABSTRACT
Lin28 acts as a repressor of microRNA processing
and as a post-transcriptional regulatory factor for a
subset of mRNAs. Here we report that in human
embryonic stem cells Lin28 facilitates the expres-
sion of the pivotal pluripotency factor Oct4 at the
post-transcriptional level. We provide evidence
that Lin28 binds Oct4 mRNA directly through high
affinity sites within its coding region and that an
interaction between Lin28 and RNA helicase A
(RHA) may play a part in the observed regulation.
We further demonstrate that decreasing RHA
levels impairs Lin28-dependent stimulation of trans-
lation in a reporter system. Taken together with
previous studies showing that RHA is required for
efficient translation of a specific class of mRNAs,
these findings suggest a novel mechanism by
which Lin28 may affect target mRNA expres-
sion and represent the first evidence of
post-transcriptional regulation of Oct4 expression
by Lin28 in human embryonic stem cells.
INTRODUCTION
Lin28 is an evolutionarily conserved RNA-binding
protein that plays a critical role in the developmental
timing in Caenorhabditis elegans (1). In the mouse, Lin28
is widely expressed in early stage embryos, with expression
declining and becoming restricted to a limited number of
tissues as embryonic development proceeds (2). In human
tissues, Lin28 expression has been detected in normal
ovarian surface epithelium and in mature oocytes (3,4).
Lin28 expression is high in human and mouse embryonic
stem (ES) cells, and decreases dramatically during ES cell
diﬀerentiation (5,6). The biological importance of Lin28 is
further underscored by its ability to facilitate the
reprogramming of human somatic cells to induced
pluripotent stem (iPS) cells (7).
Predominantly cytoplasmic, Lin28 plays pleiotropic
roles in the regulation of gene expression. Lin28 has
been shown to block let-7 microRNA processing in
embryonic cells (8–12). Two recent studies, however,
have demonstrated that the let-7 family microRNAs are
not the only targets of Lin28 regulation—a handful of
other microRNAs are also substrates of Lin28 inhibition
(13,14). Lin28 has also been reported to bind a speciﬁc
subset of mRNAs and to modulate their translation. For
example, in diﬀerentiating skeletal muscle cells,
Polesskaya et al (15) demonstrated that Lin28 binds
IGF-2 mRNA and stimulates its translation. Similarly,
our studies using mouse ES cells identiﬁed mRNAs of a
subset of cell cycle-related genes as putative Lin28
targets (16,17). In an attempt to further understand
Lin28-mediated translational regulation in muscle cells,
Polesskaya et al (15) performed aﬃnity chromatography
and proteomics analysis and found that the translation
initiation factor eIF3beta interacts speciﬁcally with
Lin28, suggesting a role for Lin28 in the modulation of
translation initiation. However, this interaction has not
yet been reported in other cell types.
Oct4, known also as Oct3 and Oct3/4, is a POU-domain
transcription factor that regulates transcription via
binding to an octamer motif located in the promoter
and enhancer regions of target genes (18). The mouse
and human Oct4 orthologs exhibit a high conservation
of nucleotide sequence and genomic organization.
Essential for regulating cell fate during early development,
Oct4 is also critical for maintaining self-renewal and
pluripotency of ES cells. A less than two-fold increase in
Oct4 level results in ES cell diﬀerentiation into primitive
endoderm and mesoderm, while reduction of Oct4 expres-
sion induces diﬀerentiation towards trophectoderm, sug-
gesting that a precise level of Oct4 is required for
maintaining pluripotency (19). To further highlight its
key role in pluripotency, Oct4 was recently demonstrated
to be both necessary and suﬃcient to reprogram mouse
adult neural stem cells to pluripotency (20). These results
also suggest that ES cells must possess a sophisticated
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optimal level. In line with this view, multiple factors
have been identiﬁed that regulate Oct4 expression at the
transcriptional level. Among the well-studied regulators
are Nanog, Sox2, FoxD3 and Oct4 itself, which partner
with one another to activate the transcription of Oct4.
In fact, Oct4 represses its own transcription when
over-expressed (18). Thus, these factors apparently work
in concert to establish regulatory circuitry composed of
autoregulatory and feed-forward loops that contribute
to the maintenance of pluripotency and self-renewal.
In this report, we reveal a novel mechanism of regula-
tion of Oct4 expression: regulation at the post-
transcriptional level by Lin28. Importantly, we identify
RNA helicase A (RHA) as a novel interacting partner of
Lin28 and provide evidence that this interaction may play
a role in the Lin28-mediated post-transcriptional regula-
tion of gene expression.
MATERIALS AND METHODS
Antibodies, plasmids and siRNAs
The anti-Lin28 antibody (Abcam, ab46020), anti-RHA
(Abcam, ab54593), anti-beta-actin (Sigma, A2228),
anti-beta-tubulin (Abcam, ab6046), anti-gapdh (Abcam,
ab9484), anti-Oct4 (Chemicon, AB3209), anti-Flag
(Sigma, F3165), anti-PABP (Santa Cruz, sc-32318),
anti-eIF3beta (Santa Cruz, sc-30251) and rabbit
pre-immune serum (SouthernBiotech, 0040-01) were
purchased. siLin28 (ON-TARGETplus SMARTpool,
L-018411-01), siLin28-2 (an equal molar mixture of two
siRNAs, J-018411-09 and J-018411-11), siRHA
(ON-TARGETplus SMARTpool, L-009950-00-0005)
and consiRNA (D-001810-10-05) were purchased from
Dharmacon.
Cell culture and siRNA transfection
Human ES line H1 (listed in the NIH hES registry under
the name WA01, WiCell) was maintained as undif-
ferentiated state by culturing on Matrigel-coated plates
(B&D) in feeder-free and components deﬁned conditions
to avoid any feeder-related contamination to the experi-
ment (21). Brieﬂy, cells were cultured in DMEM/F12
media (Invitrogen, Carlsbad, CA, USA) supplemented
with 1% MEM-nonessential amino acids (Invitrogen),
1mML-glutamine, 1% penicillin-streptomycin (P/S),
50ng/ml basic ﬁbroblast growth factor (Millipore), 1X
N2 supplements (Invitrogen), and 1X B27 supplements
(Invitrogen), and with daily media change. Cells were
passaged weekly by dissociation with 1mg/mL Dispase
(StemCell technology). The H1 cells used were between
passages 30 and 70 with normal karyotype and expressed
common hES cell markers. PA-1 and HEK293 cells were
cultured using standard protocols provided by ATCC. Cell
transfections were carried out as described (22).
Protein extraction and Western blot analyses
These were done as described by Xu et al. (16).
IP, RNA extraction and RT-qPCR
These were carried out based on protocols as previously
described (16). The RT primers speciﬁc for the human
genes are: beta-actin forward: 50-ATCAAGATCATTGC
TCCTCCTGAG; beta-actin reverse: 50-CTGCTTGCTG
ATCCACATCTG; tubulin forward: 50-CGTGTTCGGC
CAGAGTGGTGC, tubulin reverse: 50-GGGTGAGGGC
ATGACGCTGAA; Lin28 forward: 50-CGGGCATCTGT
AAGTGGTTC, Lin28 reverse: 50-CAGACCCTTGGCT
GACTTCT; Oct4 forward: 50- GCCGGTTACAGAACC
ACACT, Oct4 reverse: 50-GTGGAGGAAGCTGACAA
CAA. Fireﬂy luciferase forward: 50-GCTGGGCGTTAA
TCAGAGAG, Fireﬂy luciferase reverse: 50-GTGTTCGT
CTTCGTCCCAGT; Renilla forward: 50-GCAAATCAG
GCAAATCTGGT, Renilla reverse: 50-GGCCGACAAA
AATGATCTTC. Nanog forward: 50-TGCCTCACACG
GAGACTGTC, Nanog reverse: 50-TGCTATTCTTCGG
CCAGTTG. Sox2 forward: 50-ACACCAATCCCATC
CACACT, Sox2 reverse: 50-GCAAACTTCCTGCAA
AGCTC.
Sucrose gradient polysome fractionation
2 10
7 H1 cells were collected, washed with PBS, and
homogenized in 0.5mL of MCB buﬀer [100mM KOAc,
0.1% Triton, 50mM HEPES, pH 7.4, 2mMMg (OAc)2,
10% glycerol, 1mM DTT, 20U/mL RNase out
(invitrogen), 1X complete mini EDTA-free protease inhib-
itor cocktail (Roche)]. The lysate was centrifuged at 1300g
at 4 C for 10min. The supernatant was applied onto the
top of a 15–55% (W/W) linear sucrose gradient made by
Density Gradient Fractionation System (Teledyne ISCO
Inc.). The gradient was centrifuged at 150000g for 3h
(Beckman, CA, USA). Fractions (0.3ml) were collected,
and polysome fractions pooled and used for IP. IP were
carried out essentially as described above with some mod-
iﬁcations. Brieﬂy, pooled polysome fractions in a total
of  4ml were divided into two tubes and incubated
with protein A sepharose beads pre-bound with either
anti-Lin28 antibody or pre-immune IgG at 4 C overnight.
The following day, beads were collected and washed with
MCB buﬀer supplemented with 250mM NaCl. Bound
RNAs were extracted and used in RT-qPCR analysis.
Fireﬂy reporter constructs and Luciferase activity assays
The various ﬁreﬂy reporter constructs were created by
inserting the indicated fragments generated by PCR
using the human Oct4 gene (NM_203289) as a template.
The fragments were inserted into the 30 UTR of the parent
ﬁreﬂy reporter opened at NotI and XhoI. The resulting
clones were conﬁrmed by sequencing. The B1U1 luciferase
construct was described previously (16). The constructs
were transfected into HEK293 cells, together with
increasing amounts of Flag-Lin28 DNA. In addition, a
Renilla reporter was included in all transfections for nor-
malization purposes. Transfection was carried out in a
48-well plate scale. The amount of total plasmid DNA
per well was 400ng that included 100ng of ﬁreﬂy
reporter DNA, 2ng of Renilla DNA, and the indicated
amounts of Flag-Lin28. Luciferase activities were
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the Dual Luciferase Assay System (Promega) according to
the manufacturer’s instructions. Luciferase mRNA levels
were determined by RT-qPCR and levels plotted after
normalization against beta-tubulin and Renilla mRNAs.
In the case of the combined RHA siRNA knockdown and
luciferase assays, HEK293 cells were transfected with
siRHA or control siRNA as usual. Seventy-two hours
later, cells were transfected with the indicated plasmid
DNAs which include 100ng of ﬁreﬂy reporter DNA con-
taining the Oct4 R2, 2ng of Renilla DNA, and 0 or 20ng
of Flag-Lin28. Luciferase activities were assayed
24h later.
In vitro transcription and UV-XL assays
These were performed as previously described (17).
Brieﬂy, 50 T7 promoter-containing transcription templates
were created by PCR using the ﬁreﬂy reporter constructs
described above as templates. The resulting PCR frag-
ments were gel puriﬁed and used to generate R2, R3, R4
and B1U1 RNAs using MEGAscript T7 (Ambion,
AM1334) according to the manufacturer’s instructions.
The resulting RNA fragments were used in the XL and
competition assays. To prepare cell extract for XL,
Flag-Lin28 was transfected into HEK293 cells and cell
extracts prepared 24h later by incubating cells in 10 cell
volumes of lysis buﬀer [0.5% Triton X-100, 10mM NaCl,
10mM Tris–HCl, pH 7.5, 10mM EDTA, 0.5mM PMSF,
1mM DTT, 1X protease inhibitor cocktail (Calbiochem)]
on ice for 20min, followed by centrifugation to remove
insoluble material. In a 40 ml of XL reaction, there were 2
ml of extract, 20 nM of in vitro transcribed and
32P-UTP
labeled F2 or F3 RNA, 6.5 ml of XL buﬀer (1mM MgCl2,
280mM KCl, 1mg/ml of yeast total RNA, 35mg/ml of
heparin, 20mM HEPES, pH 7.9, 3% glycerol, and 1mM
DTT), and 140, 420, and 1260 nM of the indicated
unlabeled competitor RNA. The mixture was incubated
at 30 C for 5min and then exposed to UV light
(254nm) on ice for 5min. After RNase A (working con-
centration 1mg/ml) treatment at 37 C for 30min,
cross-linked product was immunoprecipitated in 300 ml
of IP buﬀer (10mM Tris–HCl, pH 7.5, 150mM NaCl,
10mM EDTA, 0.5% Triton X-100, 0.5mM PMSF,
1mM DTT, 1X protease inhibitor cocktail) containing
10 ml of protein A Sepharose pre-bound to 20mgo f
anti-Flag antibody. IP was carried out at 4 C overnight.
After washing 5 times with 1ml of cold IP buﬀer,
bound proteins were eluted using 3  SDS sample buﬀer
and resolved on 12% SDS–PAGE, followed by
autoradiography.
Immunoﬂuorescence
These were carried out as described previously (22). The
polyclonal anti-Lin28 and anti-Oct4, and the monoclonal
anti-RHA were used at 1:2000, 1:1000 and 1:500 dilu-
tions, respectively.
RESULTS
Lin28 speciﬁcally associates with Oct4 mRNA in
embryonic cells
In our previous work with mouse ES cells, we noticed a
speciﬁc enrichment of Lin28 in ribonucleoprotein (RNP)
complexes containing Oct4 mRNA (17). To explore the
possibility of Oct4 mRNA being a regulatory target of
Lin28, we performed immunoprecipitation (IP) experi-
ments. We used an antibody speciﬁc for Lin28 (11,17) to
isolate RNPs from human embryonic stem (hES) cell
line H1 and embryonic carcinoma (EC) PA-1 cells. Both
cells express Lin28 and Oct4, which are localized
predominantly to the cytoplasm and nucleus, respectively
(Supplementary Figure S1). Following IP, RNAs were
extracted from the IP complexes and used to generate
cDNAs that were subsequently subjected to quantitative
real-time PCR (RT-qPCR) analysis. In Figure 1 (upper panels),
Figure 1. Lin28 is speciﬁcally enriched in Oct4 mRNA-containing
RNPs. RNPs were isolated from H1 (A) or PA-1 cells (B) using
anti-Lin28 antibody or pre-immune rabbit serum, followed by RNA
extraction and RT-qPCR analysis. Upper panels: relative abundance
of the indicated mRNAs associated with anti-Lin28 versus pre-immune
IP complexes plotted as relative fold enrichment. Bottom panels:
relative mRNA levels after normalization against beta-tubulin mRNA
levels in the cell extracts. Error bars are mean±SD (n=3).
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complexes (blue bars) relative to those in the pre-immune
IgG IP complexes (which were arbitrarily set as 1, red
bars) are shown. Beta-actin mRNA was used as a
control for non-speciﬁc RNA binding. While Oct4
mRNA exhibited  5-fold enrichment in the
Lin28-containing RNPs in both H1 and PA-1 cells, the
mRNAs for Nanog and Sox2, two other pluripotency
factors, did not. The preferential enrichment of Oct4
mRNA in the Lin28-containing complexes likely reﬂects
its high aﬃnity for Lin28, which is suggested by the lack of
enrichment of the actin mRNA that is present at a com-
parable level in the extract (Figure 1, bottom panels).
Therefore, these results together suggest that Oct4
mRNA could be a target for Lin28 regulation at the
post-transcriptional level.
Down-regulation of Lin28 expression reduces
Oct4 protein levels
Evidence exists that Lin28 acts to stimulate the translation
of target mRNAs (15–17). We therefore asked whether
Lin28 aﬀects Oct4 translation. First, we performed
siRNA knockdown experiments to assess the eﬀect of
Lin28 depletion on Oct4 expression. Lin28-speciﬁc
siRNA (6) or a control siRNA was transfected into H1
or PA-1 cells. Seventy-two hours later, RNAs and proteins
were extracted from the transfected cells and subjected to
RT-qPCR and Western blot analysis, respectively. We
observed an average of 87–88% reduction of Lin28 at
the protein level in Lin28 siRNA transfected compared
to control siRNA transfected H1 and PA-1 cells, respec-
tively (Figure 2, left panels, top blots, compare lanes 2
to 1). Importantly, we also observed an average of
37–41% reduction in Oct4 protein levels in H1 and PA-1
cells, respectively, that were transfected with Lin28 siRNA
versus control siRNA (Figure 2, left panels, second blots
from the top, compare lanes 2 to 1), while the
housekeeping Gapdh protein levels were not signiﬁcantly
aﬀected (Figure 2, left panels, third blots from the top,
compare lanes 2 to 1). The eﬃcacy and speciﬁcity of the
Lin28 siRNA was conﬁrmed by RT-qPCR. As shown in
Figure 2, right panels, transfection of Lin28-speciﬁc
siRNA leads to a reduction in Lin28 mRNA level by at
Figure 2. Lin28 depletion leads to decreased levels of Oct4 in hES cells and EC cells. H1 (A) or PA-1 cells (B) were transfected with control siRNA
(consiRNA) or Lin28-speciﬁc siRNA (siLin28). Seventy-two hours later, RNAs and proteins were extracted from transfected cells, and the levels
measured by RT-qPCR and Western blot, respectively. In the left panels, representative results of two Western blot analyses are shown. In lanes 1
and 2, cells were transfected with consiRNA and siLin28, respectively. The antibodies used in the Western blot analyses are labeled on the left. The
Lin28, Oct4 and Gapdh protein levels in siLin28-transfected cells relative to those in consiRNA-transfected cells (which were set as 100%) are shown
on the right. Protein levels on Western gels were determined using Bio-Rad Quantity One software, and calculated after normalization against
beta-tubulin loading control. Average numbers of two (A) or three (B) independent experiments are presented. In the right panels, relative mRNA
levels are shown after normalization against beta-tubulin control. mRNA levels in cells transfected with consiRNA were arbitrarily set as 1. Numbers
are mean±SD (n=3).
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control siRNA. Meanwhile, the levels of the untargeted
Oct4 and beta-actin mRNAs were not aﬀected, suggesting
that the Lin28 siRNA eﬀect was speciﬁc. We also tested
Lin28-speciﬁc siRNAs targeted to diﬀerent regions of
Lin28 mRNA and obtained similar knockdown eﬀects
(Supplementary Figure S2). While this appears to be in
contrast to our previous work with mouse ES cells
where we did not observe a decrease in Oct4 protein
level following Lin28 siRNA treatment (16), it is likely
that the discrepancy is due to insuﬃcient Lin28 knock-
down in the previous experiments. Insuﬃcient Lin28
knockdown may also account for the failure to observe
Oct4 level reduction in hES cells, which was indicated
by the estimated siRNA knockdown eﬃciency of
<70% (6). Consistent with this, we have been unable
to observe signiﬁcant Oct4 protein level decreases in
experiments where Lin28 knockdown eﬃciencies were
<80% (data not shown). Taken together with the fact
that Oct4 mRNA levels were not aﬀected by Lin28
siRNA knockdown (Figure 2, right panels), our results
suggest that Lin28 may regulate Oct4 at the translational
level.
Based on the fact that mRNAs actively being translated
are associated with polysomes, we asked whether Lin28 is
associated with Oct4 mRNA in polysomes. Thus, we
carried out IP experiments using polysome fractions
prepared from H1 cells. We reasoned that if stimulation
of translation by Lin28 is target mRNA-speciﬁc, we would
expect to see an enrichment of a target mRNA in
Lin28-containing polysomes, while non-target mRNAs
would not be enriched. Consistent with this prediction,
we observed a reproducible 2-fold enrichment of Oct4
mRNA in Lin28-associated polysomes, while no enrich-
ment was seen with mRNAs for Nanog, Sox2 and
beta-actin (Figure 3). The observed diﬀerence in the fold
of enrichment between IP RNP (5-fold enrichment, Figure
1A) and polysomes (2-fold enrichment, Figure 3B) is likely
due to the diﬀerent conditions used for the two types of IP
experiments. Taken together, these results suggest that
Lin28 may play a role in Oct4 mRNA translation.
Oct4 mRNA coding region contains sequence elements
capable of translational stimulation
To provide further evidence supporting Lin28’s role in the
regulation of Oct4 mRNA translation, we utilized a
luciferase reporter system (16,17,23). To ask whether
Oct4 mRNA contains sequence elements that stimulate
translation in a Lin28-dependent fashion, we used a
previously described strategy (16,17) to initiate mapping
the sequences. Thus, we inserted fragments derived from
various regions of the Oct4 mRNA (Figure 4A) into the
30 untranslated region (30 UTR) of a ﬁreﬂy luciferase
reporter construct (Figure 4B, upper panel). The ability
of the individual sequences to stimulate the translation of
the reporter transcript was measured. As shown in Figure
4C, the Oct4 R2 sequence exhibited the strongest
Lin28-dependent stimulatory eﬀect on ﬁreﬂy luciferase
activity, followed by R1. R3 and R4 did not have
eﬀects, as was the case for the negative control B1U1
sequence, which was derived from the 30UTR of mouse
cyclin B1 mRNA (16). Importantly, our RT-qPCR
analysis conﬁrmed that the alterations in the luciferase
activity did not result from changes in the luciferase
mRNA levels (Figure 4D). These results suggest that the
Oct4 mRNA coding region contains cis-acting sequence
elements capable of translational stimulation in a
Lin28-dependent fashion.
The coding region of Oct4 mRNA contains
recognition sites for Lin28
To ask whether R2 preferentially binds Lin28, we per-
formed in vitro UV-crosslinking (XL) experiments
similar to those described previously (17). XL reveals
Figure 3. Lin28 preferentially associates with Oct4 mRNA in polysomes. (A) Polysome proﬁle of H1 cells. Cell lysate was fractionated through a
15–55% linear sucrose gradient and the polysome proﬁle recorded. (B) Polysome fractions were pooled and subjected to IP using anti-Lin28 or
preimmune serum as a negative control. RNAs were extracted from the IP complexes, followed by RT-qPCR. Relative abundance of the indicated
mRNAs associated with anti-Lin28 (blue bars) versus pre-immune IP complexes (red bars) were plotted as relative fold enrichment after normal-
ization against beta-tubulin mRNA levels. Error bars are mean±SD (n=3).
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natural photoreactivity of nucleic acids and amino acids
upon UV irradiation. Given that the speciﬁc aﬃnity of
Lin28 for let-7 microRNA precursors is relatively low
(10), it is not surprising that Lin28 can be crosslinked
nonspeciﬁcally to many RNAs (17; Supplementary
Figure S3). This is not unprecedented, as other
sequence-speciﬁc RNA-binding proteins such as the
fragile X mental retardation protein (FMRP) have been
reported to do so (24).
To characterize the interaction between R2 and Lin28,
a ﬁxed amount of radioactively labeled R2 RNA was
incubated with an extract of HEK293 cells (which do
not express endogenous Lin28) transfected with
Flag-Lin28, in the presence of increasing amounts of
unlabeled R2, R3, R4 and B1U1 RNA fragments
(Figure 5A). The reactions were UV-irradiated, followed
by RNase digestion. Cross-linked Lin28 was captured by
IP using an anti-Flag antibody and visualized by
autoradiography. Figure 5A shows a representative gel
image of three independent XL experiments. Lin28
binding to the radioactively labeled R2 RNA was
competed far more eﬃciently by the unlabeled R2 RNA
itself than by any of the others (compare lanes 3–5 with
lanes 6–14). Under the conditions used, the aﬃnity of R2
RNA for Lin28 was estimated as  4-fold higher than that
of R3 and R4 RNAs (Figure 5B). When labeled R3 was
used, more eﬃcient competition by R2 RNA compared to
R3, R4 and B1U1 RNAs was also observed
(Supplementary Figure S3). These results suggest that
Lin28 preferentially binds to R2 in vivo.
Lin28 interacts with RHA
The above results together provide compelling evidence
that Lin28 binds Oct4 mRNA through speciﬁc recognition
of high aﬃnity sequences within the coding region and
acts to facilitate Oct4 translation. To further dissect the
molecular mechanism by which Lin28 may modulate
Oct4 translation, we set out to identify Lin28-interacting
proteins in hES cells. We hypothesized that Lin28 stimu-
lates Oct4 mRNA translation by actively recruiting com-
ponents of translational machinery to the mRNA. Thus,
we performed co-IP experiments using the anti-Lin28
antibody to isolate Lin28-containing protein complexes
from H1 cells. Co-IP was carried out in the presence of
an excess amount of RNase A to disrupt any
RNA-bridged interactions that are formed through two
RNA-binding proteins simultaneously binding to the
same RNA molecule. Protein components in the
Lin28-containing complexes were resolved by SDS–
PAGE, followed by mass spectrometry analysis of
protein bands that were present in the anti-Lin28 IP
complexes and not in the pre-immune IP complexes. We
identiﬁed RHA as a putative Lin28-interacting protein
(Supplementary Figure S4). This was subsequently con-
ﬁrmed by co-IP and Western blot analyses. As shown in
Figure 6, while  90% of Lin28 was immunoprecipitated
by the anti-Lin28 antibody (lane 4, top panel),  16%
of RHA was also brought down by the anti-Lin28
co-IP (Lane 4, second panel from the top). Importantly,
the interaction between Lin28 and RHA is direct
since poly(A)-binding protein (PABP), which binds to all
polyadenylated mRNAs, was not present in the anti-Lin28
Figure 4. Luciferase reporter assays. (A) A schematic drawing of human Oct4 mRNA. The orange box represents the open reading frame (ORF),
while the black line represents the 30UTR. The various fragments used to create the ﬁreﬂy luciferase reporter constructs are marked above.
The numbers in nucleotides depict positions of the fragments relative to the Oct4 transcriptional start site. (B) Schematic structures of reporter
constructs. The fragments cloned into the ﬁreﬂy luciferase reporter construct at the 30UTR (blue line) are indicated above. The sizes in nucleotides
for the R1, R2, R3, R4 and B1U1 fragments are 436, 369, 278, 217 and 297, respectively. (C) Luciferase activity results. The reporter constructs were
transfected into HEK293 cells that do not express endogenous Lin28, together with increasing amounts of Flag-Lin28. In addition, a Renilla reporter
(B) that produces red ﬂuorescence proteins was included in all transfection for normalization purposes. Luciferase activities and mRNA levels were
measured 24h post-transfection. Fireﬂy luciferase activities (after normalization against Renilla luciferase) (C) and ﬁreﬂy mRNA levels (D) from cells
without Flag-Lin28 transfection were arbitrarily set as 1. Numbers are mean±SD (n=3). B1U1 was used as a negative control for the stimulatory
activity (16).
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Interestingly, we also observed an interaction between
Lin28 and the translation initiation factor eIF3beta that
was identiﬁed by Polesskaya et al (15) as a
Lin28-interacting partner in muscle cells, although under
our assay conditions the interaction with Lin28 was much
weaker compared to RHA.
To determine whether the observed interaction is
biologically signiﬁcant, we performed RHA siRNA
knockdown experiments. Transfection of a RHA-speciﬁc
siRNA (siRHA) led to an average of 71% reduction of
RHA at the protein level (Figure 6B, compare lane 2 to 1,
top panel). Importantly, in the cells where RHA was
down-regulated, the ability of Lin28 to stimulate the
translation of a ﬁreﬂy luciferase reporter gene was also
decreased. As shown in Figure 6C, in control
siRNA-transfected cells, luciferase activity was  75%
higher in cells transfected with Flag-Lin28 than in cells
transfected with an empty vector (compare the blue bars
with and without the red asterisk). In siRHA-transfected
cells, the same level of Flag-Lin28 expression stimulated
ﬁreﬂy luciferase activity by only  30% (compare the red
bars with and without the red asterisk), a 2.5-fold reduc-
tion in the stimulation of translation. These results thus
indicate that RHA may be an important partner of Lin28
in the regulation of translation of target mRNAs.
DISCUSSION
We show here that Lin28 associates with Oct4 mRNA in
RNPs and polysomes in human ES cells and EC cells. The
functional signiﬁcance of these associations is underscored
by the fact that inhibition of Lin28 leads to reduced Oct4
protein levels and that Lin28 stimulates luciferase activity
from reporter transcripts containing putative Lin28 recog-
nition sites from the Oct4 mRNA. Taken together, these
Figure 6. Lin28 interacts with RHA. (A) Results from co-IP experiments. Lin28-containing protein complexes were immunoprecipitated in the
presence of excess amounts of RNAse A from H1 cells using anti-Lin28 or pre-immune IgG. Six percent IP supernatants (lanes 1 and 2) and co-IP
complexes (lanes 3 and 4) were resolved by SDS–PAGE, followed by Western blot analysis using the indicated antibodies shown on the left. The
estimated IP eﬃciencies were marked on the right. Bands on the Western gels were quantitated using Bio-Rad Quantity One software. (B) Results of
RHA siRNA knockdown. HEK293 cells were transfected with control siRNA (lane 1) or a siRNA speciﬁc for RHA (lane 2). Seventy-two hours
later, proteins were extracted from the transfected cells, followed by Western blot analysis. The speciﬁc RHA knockdown at the protein level was
quantitated as 71% (an average of three experiments), using beta-actin as a loading control. (C) Luciferase reporter assays. HEK293 cells were
transfected with ﬁreﬂy luciferase reporter DNA containing Lin28-binding sequences, with or without co-transfection of Flag-Lin28. The transfections
were performed 72h after the transfection of control siRNA or siRHA. Renilla luciferase was included in the plasmid DNA transfection for
normalization purposes. Luciferase activities were measured 24h following plasmid DNA transfection. Fireﬂy luciferase activities in the absence
of Flag-Lin28 expression were set as 1. Numbers are mean±SD (n=3), *P<0.01.
Figure 5. XL and competition assays. (A) Flag-Lin28 was transfected
into HEK293 cells and cell extract prepared. XL were carried out using
radioactively labeled R2 RNA in the absence (lane 2) or presence of
increasing amounts of unlabeled competitor R2 (lanes 3–5), R3
(lanes 6–8), R4 (lanes 9–11), and B1U1 (lanes 12–14), followed by IP
using anti-Flag antibody. The unlabeled RNAs were at 7 (lanes 3, 6, 9,
12), 21 (lanes 4, 7, 10, 13) and 63 (lanes 5, 8, 11, 14) molar
excess relative to the labeled R2 RNA. Five percent of total
cross-linked product prior to IP (lane 1) and anti-Flag IP products
were resolved by SDS–PAGE, followed by autoradiography. The
bands marked with * indicate Flag-Lin28. (B) Amounts of cross-linked
Flag-Lin28 plotted against unlabeled competitor RNA in molar excess.
Each point represents three independent experiments. Numbers are
mean±SD.
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Oct4 translation. We have further identiﬁed RHA as a
novel Lin28-interacting protein and provide evidence
that this interaction may be important for Lin28’s
function in regulating target mRNA translation.
In humans, two isoforms of Oct4, Oct4A and Oct4B,
are produced via alternative splicing (25). Oct4A has been
demonstrated to be essential for ‘stemness’ by acting as a
transcription factor with a pivotal role in the regulation of
expression of genes important for the maintenance of
pluripotency and the self-renewal ability of ES cells.
On the other hand, the function of Oct4B is currently
unknown, although multiple Oct4B isoforms resulting
from alternative translation initiation have been reported
(26). Owing to its clear role in pluripotency, it is not sur-
prising that cells have evolved complex mechanisms to
control Oct4 expression to ensure appropriate levels of
its expression (18). Until now, however, all pathways
involved in the regulation of Oct4 expression have been
reported to be at the transcriptional level (18). Our studies
demonstrating that Oct4 expression is also modulated at
the post-transcriptional level by another pluripotency
factor, Lin28, further highlight the complexity of this
important regulatory circuitry.
Our studies in mouse ES cells have shown that Lin28
plays a role in ES cell proliferation partly by modulating
the expression of cell cycle-related genes including those
for cyclin A, cyclin B, cdk4 and the replication-dependent
histone H2a at the post-transcriptional level (16,17). Here,
we reveal yet another function of Lin28—aﬀecting the
expression of Oct4 which is essential for the pluripotency
and self-renewal of ES cells. Taken together with the
notion that Lin28 inhibits the production of let-7
microRNAs (8–12) involved in cell growth and diﬀerenti-
ation, we speculate that all three functions of Lin28
may contribute collaboratively in the process of
reprogramming human somatic cells to iPS cells (7).
Related to this work, Darr and Benvenisty (6) have
reported that overexpression of Lin28 in human ES cells
triggers ES cell diﬀerentiation preferentially towards the
primitive endoderm lineage, a phenotype similar to that
seen when Oct4 expression was slightly elevated (<2-fold)
(19). Based on our ﬁndings that Lin28 stimulates Oct4
production, Lin28 overexpression might well lead to an
increased level of Oct4 [which was not examined in the
work of Darr and Benvenisty (6)], which subsequently
permits lineage-speciﬁc diﬀerentiation.
Despite accumulating evidence pointing to the role of
Lin28 as a target-speciﬁc translational regulator (15–17),
the precise mechanism underlying the process is unclear.
The ﬁnding that Lin28 interacts with the translation initi-
ation factor eIF3beta (this report and ref. 15) is intriguing,
given that translation initiation is the rate-limiting step of
translation. During initiation, ribosomes are recruited to
the mRNA by eukaryotic translation initiation factors
(eIFs) that include eIF4E, eIF4A, eIF4G and eIF3.
eIF3beta is one of the 13 subunits of the mammalian
eIF3 complex (27 and references therein). The interaction
between Lin28 and eIF3beta may increase the eﬃciency of
assembly of translation initiation complexes on an
mRNA, thus facilitating ribosome loading.
In addition to eIF3beta, we have identiﬁed RHA as
another Lin28-interacting partner in hES cells. RHA
(also called DHX9 and NDHII) is a highly conserved
DEAD-box protein that functions in multiple cellular pro-
cesses, including transcription, splicing, nuclear export,
translation, and RNAi, by catalyzing RNA–RNA and
RNA–protein rearrangements in RNP complexes (28).
In particular, RHA has been shown to promote transla-
tion of a speciﬁc class of mRNAs that contain highly
structured 50 UTRs (29,30). These include the cellular
JUND growth-control gene and viral transcripts that
contain a post-transcriptional control element (PCE) in
their 50 UTRs. It has been proposed that complex
50 UTR structures create a barrier for eﬃcient ribosomal
scanning of the transcripts and that direct binding
of RHA to the PCE stimulates RNA–RNA and
RNA–protein rearrangements necessary for eﬃcient
translation (29,30).
Most RNA helicases characterized in vitro lack RNA
substrate speciﬁcity, yet in vivo perform very speciﬁc func-
tions with no redundancy, supporting a view that these
RNA helicases require cofactors to convey speciﬁcity
in vivo (28). We speculate that RHA may function
through interaction with Lin28 as a cofactor to
specify its RNA substrates. This is supported by the fol-
lowing observations. First, Lin28 interacts with RHA
in an RNA-independent manner (Figure 6A). Second,
down-regulation of RHA impedes Lin28-dependent
stimulation of translation from transcripts containing
Lin28-binding sites (Figure 6B and C). Third,
Lin28-binding sequences that confer translational
stimulatory eﬀects have been mapped to 30 UTRs (16) as
well as to the coding regions of target mRNAs (17;
Figures 4 and 5), instead of 50UTRs. Fourth, we ﬁnd no
obvious sequence and/or structural similarity between the
Lin28-binding sequences and the post-transcriptional
control element PCE (29,30). We therefore postulate
that Lin28 may selectively bind RNA substrates by recog-
nition of high aﬃnity binding sites and subsequently
recruit eIF3beta (to enhance translation initiation) as
well as RHA (to facilitate RNP remodeling during trans-
lation) to enhance translation eﬃciency.
Finally, RHA has recently been reported to be
associated with RNA-induced silencing complexes
(RISC), and to promote their formation (31). In
addition, Lin28 has been shown to inhibit Dicer (a com-
ponent of the RISC) cleavage of let-7 pre-microRNAs
in vitro (9). Taken together, these observations raise the
possibility that RHA-Lin28 interaction provides a molec-
ular link between these processes.
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